JOHNSON-ANSAH , Hyacinthe

Last name: JOHNSON-ANSAH

First name: Hyacinthe

December 15, 2013 (v1)

Journal article

Metadata-only

Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia.

Johnson-Ansah, Hyacinthe Guilhot, Joelle Rousselot, Philippe

BACKGROUND: The pegylated form of interferon-α-2a (PegIFNa2a) in combination with imatinib has demonstrated a molecular improvement in patients with chronic-phase chronic myeloid leukemia. However, to the authors' knowledge, the appropriate dose of PegIFNa2a has not been established to date. METHODS: In the French SPIRIT trial, the authors...

Uploaded on: December 3, 2022
December 15, 2013 (v1)

Journal article

Metadata-only

Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia.

Johnson-Ansah, Hyacinthe Guilhot, Joelle Rousselot, Philippe

BACKGROUND: The pegylated form of interferon-α-2a (PegIFNa2a) in combination with imatinib has demonstrated a molecular improvement in patients with chronic-phase chronic myeloid leukemia. However, to the authors' knowledge, the appropriate dose of PegIFNa2a has not been established to date. METHODS: In the French SPIRIT trial, the authors...

Uploaded on: October 11, 2023
February 16, 2017 (v1)

Journal article

Metadata-only

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Rea, Delphine Nicolini, Franck Tulliez, Michel

International audience

Uploaded on: December 4, 2022

JOHNSON-ANSAH , Hyacinthe

Recent uploads